Changes in lipoprotein-Associated phospholipase A2 activity predict coronary events and partly account for the treatment effect of pravastatin: results from the Long-Term Intervention with Pravastatin in Ischemic Disease study
- Harvey White
- , John Simes
- , Ralph Stewart
- , Stefan Blankenberg
- , Elizabeth Barnes
- , Ian Marschner
- , Peter Thompson
- , Malcolm West
- , Tanja Zeller
- , David Colquhoun
- , Paul Nestel
- , Anthony Keech
- , David Sullivan
- , David Hunt
- , Andrew Tonkin
Research output: Contribution to journal › Article › peer-review
48
Citations
(Scopus)